These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 26288293

  • 1. [The use of buspirone in clinical practice].
    Levin OS.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(4):83-87. PubMed ID: 26288293
    [Abstract] [Full Text] [Related]

  • 2. Buspirone in the treatment of tardive dyskinesia.
    Ross CA.
    Med Hypotheses; 1987 Mar; 22(3):321-8. PubMed ID: 2884555
    [Abstract] [Full Text] [Related]

  • 3. Buspirone: what is it all about?
    Loane C, Politis M.
    Brain Res; 2012 Jun 21; 1461():111-8. PubMed ID: 22608068
    [Abstract] [Full Text] [Related]

  • 4. [Clinical potential and possibilities of using buspirone in the treatment of anxiety disorders].
    Dzampaev AT, Suvorova IA, Damulin IV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014 Jun 21; 114(8):94-104. PubMed ID: 25389538
    [Abstract] [Full Text] [Related]

  • 5. Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder.
    Gastfriend DR, Rosenbaum JF.
    Am J Psychiatry; 1989 Jul 21; 146(7):914-6. PubMed ID: 2568095
    [Abstract] [Full Text] [Related]

  • 6. [Azaspirodecanodiones in clinical psychiatry].
    Conde López V, Martínez Roig M.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1992 Jul 21; 20(4):155-67. PubMed ID: 1356293
    [Abstract] [Full Text] [Related]

  • 7. Augmentation with buspirone: a review.
    Harvey KV, Balon R.
    Ann Clin Psychiatry; 1995 Sep 21; 7(3):143-7. PubMed ID: 8646275
    [Abstract] [Full Text] [Related]

  • 8. The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation.
    Shin E, Lisci C, Tronci E, Fidalgo C, Stancampiano R, Björklund A, Carta M.
    Neurobiol Dis; 2014 Feb 21; 62():233-40. PubMed ID: 24135006
    [Abstract] [Full Text] [Related]

  • 9. Buspirone: future directions.
    Apter JT, Allen LA.
    J Clin Psychopharmacol; 1999 Feb 21; 19(1):86-93. PubMed ID: 9934947
    [Abstract] [Full Text] [Related]

  • 10. [Anxiety and depression. Highlights from the 149th Session of the American Psychiatric Association, New York 4-9 May 1996].
    Fortschr Neurol Psychiatr; 1997 Apr 21; 65(4 Suppl Angst Und):1-4. PubMed ID: 9330647
    [No Abstract] [Full Text] [Related]

  • 11. Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease.
    Shin E, Garcia J, Winkler C, Björklund A, Carta M.
    Neurobiol Dis; 2012 Sep 21; 47(3):393-406. PubMed ID: 22579773
    [Abstract] [Full Text] [Related]

  • 12. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
    Yamaguchi T, Tsujimatsu A, Kumamoto H, Izumi T, Ohmura Y, Yoshida T, Yoshioka M.
    J Ethnopharmacol; 2012 Sep 28; 143(2):533-9. PubMed ID: 22819689
    [Abstract] [Full Text] [Related]

  • 13. Azapirones: an alternative to benzodiazepines for anxiety.
    Cadieux RJ.
    Am Fam Physician; 1996 May 15; 53(7):2349-53. PubMed ID: 8638511
    [Abstract] [Full Text] [Related]

  • 14. [Anxiety and depression--patients with comorbidity. Advances in therapy with dual-serotonergic action].
    Nervenarzt; 1998 Dec 15; 69(12 Suppl Fortschrit):1-4. PubMed ID: 9884735
    [No Abstract] [Full Text] [Related]

  • 15. Is buspirone effective for panic disorder?
    Sheehan DV, Raj AB, Sheehan KH, Soto S.
    J Clin Psychopharmacol; 1990 Feb 15; 10(1):3-11. PubMed ID: 2407755
    [Abstract] [Full Text] [Related]

  • 16. A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerability.
    Schneider RB, Auinger P, Tarolli CG, Iourinets J, Gil-Díaz MC, Richard IH.
    Parkinsonism Relat Disord; 2020 Dec 15; 81():69-74. PubMed ID: 33070009
    [Abstract] [Full Text] [Related]

  • 17. Use of buspirone for treatment of cerebellar ataxia. An open-label study.
    Lou JS, Goldfarb L, McShane L, Gatev P, Hallett M.
    Arch Neurol; 1995 Oct 15; 52(10):982-8. PubMed ID: 7575226
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST, Park JH, Kim M.
    Headache; 2005 Sep 15; 45(8):1004-11. PubMed ID: 16109114
    [Abstract] [Full Text] [Related]

  • 19. Buspirone in clinical practice.
    Rickels K.
    J Clin Psychiatry; 1990 Sep 15; 51 Suppl():51-4. PubMed ID: 2211569
    [Abstract] [Full Text] [Related]

  • 20. Chronic anxiety: deciding the length of treatment.
    Gorman JM, Papp LA.
    J Clin Psychiatry; 1990 Jan 15; 51 Suppl():11-5. PubMed ID: 1967247
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.